I 
116TH CONGRESS 
2D SESSION 
H. R. 6863 
To authorize the imposition of sanctions with respect to the People’s Republic 
of China for its obstruction or failure to cooperate in investigations 
relating to the outbreak of COVID–19, and for other purposes. 
IN THE HOUSE OF REPRESENTATIVES 
MAY 14, 2020 
Mr. COLLINS of Georgia (for himself, Ms. CHENEY, Mr. AUSTIN SCOTT of 
Georgia, Mr. STEUBE, Mr. GUEST, Mr. TIMMONS, Mr. MARSHALL, Mr. 
BALDERSON, Mr. WALKER, Mr. RIGGLEMAN, Mr. PALAZZO, Mr. TIPTON, 
Mr. GIBBS, Mr. BILIRAKIS, Mr. HIGGINS of Louisiana, Mr. DIAZ- 
BALART, Mr. ALLEN, Mr. WALTZ, Mrs. HARTZLER, Mr. BANKS, Mr. 
RUTHERFORD, Mr. BISHOP of North Carolina, Mr. RODNEY DAVIS of Il-
linois, Mr. STIVERS, and Mr. MULLIN) introduced the following bill; 
which was referred to the Committee on Foreign Affairs, and in addition 
to the Committees on the Judiciary, Financial Services, Ways and Means, 
and Energy and Commerce, for a period to be subsequently determined 
by the Speaker, in each case for consideration of such provisions as fall 
within the jurisdiction of the committee concerned 
A BILL 
To authorize the imposition of sanctions with respect to 
the People’s Republic of China for its obstruction or 
failure to cooperate in investigations relating to the out-
break of COVID–19, and for other purposes. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
VerDate Sep 11 2014 
18:51 Jun 04, 2020
Jkt 099200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H6863.IH
H6863
pamtmann on DSKBC07HB2PROD with BILLS
SECTION 1. SHORT TITLE; TABLE OF CONTENTS. 
(a) SHORT TITLE.—This Act may be cited as the 
‘‘COVID–19 Accountability Act’’. 
(b) TABLE OF CONTENTS.—The table of contents for 
this Act is as follows: 
Sec. 1. Short title; table of contents. 
Sec. 2. Findings. 
Sec. 3. Statement of policy. 
TITLE I—SANCTIONS WITH RESPECT TO THE PEOPLE’S 
REPUBLIC OF CHINA 
Sec. 101. Sanctions with respect to the obstruction or failure of the People’s 
Republic of China to cooperate in investigations relating to the 
outbreak of COVID–19. 
TITLE II—ENSURING A SAFE AND SECURE SUPPLY OF 
PHARMACEUTICALS FOR THE UNITED STATES 
Sec. 201. Food and Drug Administration reporting requirements. 
TITLE III—ENCOURAGING THE RETURN AND DEVELOPMENT OF 
UNITED STATES INDUSTRY 
Sec. 301. Increase in alternative simplified research credit. 
Sec. 302. Special rules for certain United States manufacturers. 
Sec. 303. Domestic purchasing requirement for personal protective equipment 
acquisitions for the Strategic National Stockpile. 
TITLE IV—MATTERS RELATING TO TAIWAN 
Sec. 401. Participation of Taiwan in the World Health Organization. 
Sec. 402. Briefing on United States strategy regarding Taiwan’s international 
recognition. 
Sec. 403. Sense of Congress on the implementation of the Asia Reassurance 
Initiative Act. 
SEC. 2. FINDINGS. 
Congress makes the following findings: 
(1) The People’s Republic of China, including 
the Government of the People’s Republic of China 
and the Chinese Communist Party, has mishandled 
its management and response to the outbreak of 
VerDate Sep 11 2014 
18:51 Jun 04, 2020
Jkt 099200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H6863.IH
H6863
pamtmann on DSKBC07HB2PROD with BILLS
coronavirus disease 2019 (commonly known as 
‘‘COVID–19’’) in Wuhan, Hubei Province. 
(2) On December 31, 2019, the World Health 
Organization headquarters in Geneva learned of 
pneumonia with an unknown cause, not from Chi-
nese authorities, but from a United States-based 
listserv, Pro-MED, a platform for sharing early, 
open-source intelligence about potential epidemics. 
(3) On January 9, 2020, the Chinese Com-
munist Party officially announced a coronavirus out-
break, 2 days after the World Health Organization 
announced an outbreak and 8 days after closing the 
Wuhan Hua’nan wet market. 
(4) The Chinese Communist Party continually 
suppressed medical information, such as early 
knowledge of the risk of human-to-human trans-
mission of the SARS–CoV–2 virus, which causes 
COVID–19, from doctors and medical professionals 
while subjecting them to humiliating reprimands. 
(5) On January 20, 2020, the Chinese Com-
munist Party finally acknowledged that the SARS– 
CoV–2 virus can be transmitted human to human, 
despite denials as recently as January 15, 2020. 
(6) On January 2, 2020, researchers in the 
People’s Republic of China completed a genomic 
VerDate Sep 11 2014 
18:51 Jun 04, 2020
Jkt 099200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H6863.IH
H6863
pamtmann on DSKBC07HB2PROD with BILLS
analysis of the SARS–CoV–2 virus, but failed to 
share the results with the international community 
until January 12, 2020. 
(7) On January 6, 2020, officials from the 
United States Centers for Disease Control and Pre-
vention offered to visit the People’s Republic of 
China to help respond to the COVID–19 epidemic, 
but the offer was declined by the Chinese Com-
munist Party, and the Centers for Disease Control 
and Prevention were informed that United States 
medical researchers were not permitted to enter the 
People’s Republic of China until February 16, 2020, 
as part of a World Health Organization delegation. 
(8) The Chinese Communist Party exponen-
tially increased the spread of COVID–19 domesti-
cally and internationally by continuing to permit 
international flights well after domestic quarantines 
were put in place. 
(9) The Chinese Communist Party contributed 
to the community spread of COVID–19 by, on Janu-
ary 18, 2020, permitting a 40,000-family potluck 
banquet in the Bubuting Community of Wuhan as 
part of the Lunar New Year festivities. 
(10) On March 12, 2020, officials within the 
Chinese 
Communist 
Party 
knowingly 
spread 
VerDate Sep 11 2014 
18:51 Jun 04, 2020
Jkt 099200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\H6863.IH
H6863
pamtmann on DSKBC07HB2PROD with BILLS
disinformation that the SARS–CoV–2 virus had 
originated with the United States Armed Forces. 
(11) COVID–19 has decimated the global econ-
omy, caused trillions of dollars in economic damage, 
and cost millions of United States citizens their jobs. 
(12) As of the end of April 2020, COVID–19 
has— 
(A) infected more than 3,000,000 individ-
uals globally and almost 1,000,000 people in 
the United States; and 
(B) caused more than 200,000 deaths 
globally and more than 50,000 deaths in the 
United States. 
SEC. 3. STATEMENT OF POLICY. 
It is the policy of the United States— 
(1) to fully investigate the outbreak of the 
SARS–CoV–2 virus, including the role the Govern-
ment of the People’s Republic of China and the Chi-
nese Communist Party played in withholding infor-
mation and knowingly misinforming international or-
ganizations and countries impacted by COVID–19; 
(2) to ensure that the Government of the Peo-
ple’s Republic of China immediately closes all oper-
ating wet markets that have a potential to expose 
VerDate Sep 11 2014 
18:51 Jun 04, 2020
Jkt 099200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6201
E:\BILLS\H6863.IH
H6863
pamtmann on DSKBC07HB2PROD with BILLS
humans to health risks through the introduction of 
zoonotic disease into the human population; 
(3) to draw international attention to— 
(A) any violations by the Government of 
the People’s Republic of China of the funda-
mental rights of the people of Hong Kong, as 
provided by the International Covenant on Civil 
and Political Rights; and 
(B) any encroachment on the autonomy 
guaranteed to Hong Kong by the Basic Law of 
Hong Kong and the Joint Declaration of the 
Government of the United Kingdom of Great 
Britain and Northern Ireland and the Govern-
ment of the People’s Republic of China on the 
Question of Hong Kong, done at Beijing on De-
cember 19, 1984; and 
(4) to reduce the reliance of essential United 
States industries on the People’s Republic of China 
to fulfill supply chain needs. 
VerDate Sep 11 2014 
18:51 Jun 04, 2020
Jkt 099200
PO 00000
Frm 00006
Fmt 6652
Sfmt 6201
E:\BILLS\H6863.IH
H6863
pamtmann on DSKBC07HB2PROD with BILLS
TITLE I—SANCTIONS WITH RE-
SPECT TO THE PEOPLE’S RE-
PUBLIC OF CHINA 
SEC. 101. SANCTIONS WITH RESPECT TO THE OBSTRUC-
TION OR FAILURE OF THE PEOPLE’S REPUB-
LIC OF CHINA TO COOPERATE IN INVESTIGA-
TIONS RELATING TO THE OUTBREAK OF 
COVID–19. 
(a) CERTIFICATION REQUIRED.—Not later than 60 
days after the date of the enactment of this Act, and every 
180 days thereafter, the President shall submit to Con-
gress— 
(1) a certification that the Government of the 
People’s Republic of China— 
(A) is completely cooperating with any ef-
forts relating to the COVID–19 outbreak led by 
the United States, partners of the United 
States, or any institution affiliated with the 
United Nations; 
(B) has prohibited the operation of wet 
markets that have a potential to expose humans 
to health risks through the introduction of 
zoonotic disease into the human population; and 
(C) has released and dropped all charges 
for anyone arrested or detained in the People’s 
VerDate Sep 11 2014 
18:51 Jun 04, 2020
Jkt 099200
PO 00000
Frm 00007
Fmt 6652
Sfmt 6201
E:\BILLS\H6863.IH
H6863
pamtmann on DSKBC07HB2PROD with BILLS
Republic of China since November 2019 relat-
ing to their participation in the protests in 
Hong Kong relating to COVID–19; or 
(2) a report describing the reasons the Presi-
dent is not able to make the certification described 
in paragraph (1). 
(b) IMPOSITION
OF
SANCTIONS
AND
PROHIBI-
TIONS.—If the President is unable to make a certification 
described in paragraph (1) of subsection (a) by a date re-
quired by that subsection, the President may impose 2 or 
more of— 
(1) the sanctions described in subsection (c) 
with respect to— 
(A) any official of the Government of the 
People’s Republic of China; 
(B) any entity owned, directed, or other-
wise controlled by that Government; and 
(C) any individual associated with an enti-
ty described in paragraph (2); or 
(2) the prohibition described in subsection (d). 
(c) SANCTIONS DESCRIBED.—The sanctions that 
may be imposed with respect to an official, entity, or indi-
vidual under this subsection are the following: 
(1) PROPERTY BLOCKING.—The President may, 
pursuant to the International Emergency Economic 
VerDate Sep 11 2014 
18:51 Jun 04, 2020
Jkt 099200
PO 00000
Frm 00008
Fmt 6652
Sfmt 6201
E:\BILLS\H6863.IH
H6863
pamtmann on DSKBC07HB2PROD with BILLS
Powers Act (50 U.S.C. 1701 et seq.), block and pro-
hibit all transactions in property and interests in 
property of such an official, entity, or individual 
(and, in the case of an official or other individual, 
the immediate family members of the official or indi-
vidual) if such property and interests in property are 
in the United States, come within the United States, 
or are or come within the possession or control of a 
United States person. 
(2) ALIENS INELIGIBLE FOR VISAS, ADMISSION, 
OR PAROLE.— 
(A) VISAS, ADMISSION, OR PAROLE.—Not-
withstanding section 221 of the Immigration 
and Nationality Act (8 U.S.C. 1201), the Sec-
retary of State may deny a visa to, and the Sec-
retary of Homeland Security may deny admis-
sion or parole into the United States for, such 
an official or individual who is an alien. 
(B) CURRENT VISAS REVOKED.— 
(i) IN GENERAL.—Pursuant to section 
221(i) of the Immigration and Nationality 
Act (8 U.S.C. 1201(i)), the issuing con-
sular officer, the Secretary of State, or the 
Secretary of Homeland Security (or a des-
ignee of any such officer or Secretary) may 
VerDate Sep 11 2014 
18:51 Jun 04, 2020
Jkt 099200
PO 00000
Frm 00009
Fmt 6652
Sfmt 6201
E:\BILLS\H6863.IH
H6863
pamtmann on DSKBC07HB2PROD with BILLS
revoke any visa or other entry documenta-
tion issued to an alien described in sub-
paragraph (A), regardless of when the visa 
or other documentation was issued. 
(ii) EFFECT OF REVOCATION.—A rev-
ocation under clause (i) may take effect 
immediately and shall automatically cancel 
any other valid visa or entry documenta-
tion that is in the alien’s possession. 
(3) LOANS FROM UNITED STATES FINANCIAL 
INSTITUTIONS.—The President may prohibit any 
United States financial institution from making 
loans, underwriting, or providing credits to any such 
entity unless the entity is determined by the United 
States Government to be engaged in activities to re-
lieve human suffering and the loans or credits have 
been approved by the United States Government for 
such activities. 
(4) LOANS
FROM
AND
PROCUREMENT
BY 
INTERNATIONAL
FINANCIAL
INSTITUTIONS.—The 
President shall direct the United States executive di-
rector of each international financial institution (as 
defined in section 1701(c) of the International Fi-
nancial Institutions Act (22 U.S.C. 262r(c))) to use 
the voice and vote of the United States to oppose— 
VerDate Sep 11 2014 
18:51 Jun 04, 2020
Jkt 099200
PO 00000
Frm 00010
Fmt 6652
Sfmt 6201
E:\BILLS\H6863.IH
H6863
pamtmann on DSKBC07HB2PROD with BILLS
(A) any financial assistance from the inter-
national financial institution that would benefit 
any such entity; and 
(B) the awarding by the international fi-
nancial institution of procurement contracts to 
any such entity. 
(5) LIMITATION ON CHINESE OWNERSHIP IN-
TERESTS IN UNITED STATES ISSUERS OF SECURI-
TIES.— 
(A) IN GENERAL.—The Securities and Ex-
change Commission may prohibit a covered en-
tity from listing securities issued by the entity 
on a national securities exchange if an entity or 
individual subject to subsection (b) has a ma-
jority ownership interest in the covered entity. 
(B) DEFINITIONS.—In this paragraph: 
(i) 
COVERED
ENTITY.—The 
term 
‘‘covered entity’’ means an entity— 
(I) that is incorporated under the 
laws of any State, or whose principal 
place of business is within a State; 
and 
(II) that produces components 
that may be used in— 
VerDate Sep 11 2014 
18:51 Jun 04, 2020
Jkt 099200
PO 00000
Frm 00011
Fmt 6652
Sfmt 6201
E:\BILLS\H6863.IH
H6863
pamtmann on DSKBC07HB2PROD with BILLS
(aa) services supplied by an 
entity subject to subsection (b); 
or 
(bb) goods produced, or ex-
ported, by an entity subject to 
subsection (b). 
(ii) 
EXCHANGE; 
SECURITY.—The 
terms ‘‘exchange’’ and ‘‘security’’ have the 
meanings given those terms in section 3(a) 
of the Securities Exchange Act of 1934 
(15 U.S.C. 78c(a)). 
(iii) MAJORITY
OWNERSHIP
INTER-
EST.—An entity or individual holds a ‘‘ma-
jority ownership interest’’ in a covered en-
tity if the entity or individual owns— 
(I) more shares in the covered 
entity than any other shareholder; and 
(II) enough shares in the covered 
entity to control decisions of the enti-
ty. 
(iv) 
NATIONAL
SECURITIES
EX-
CHANGE.—The term ‘‘national securities 
exchange’’ means an exchange that is reg-
istered as a national securities exchange 
VerDate Sep 11 2014 
18:51 Jun 04, 2020
Jkt 099200
PO 00000
Frm 00012
Fmt 6652
Sfmt 6201
E:\BILLS\H6863.IH
H6863
pamtmann on DSKBC07HB2PROD with BILLS
under section 6 of the Securities Exchange 
Act of 1934 (15 U.S.C. 78f). 
(d) PROHIBITION AGAINST STUDENT VISAS
FOR 
CHINESE NATIONALS.—The Secretary of State may deny 
an alien who is a citizen or national of the People’s Repub-
lic of China admission, parole, or other permission to enter 
the United States as a nonimmigrant described in sub-
paragraph (F), (J), or (M) of section 101(a)(15) of the 
Immigration and Nationality Act (8 U.S.C. 1101(a)(15)). 
(e) APPLICATION; EXCEPTIONS.— 
(1) INAPPLICABILITY
OF
NATIONAL
EMER-
GENCY
REQUIREMENT.—The requirements under 
section 202 of the International Emergency Eco-
nomic Powers Act (50 U.S.C. 1701) shall not apply 
for purposes of subsection (c)(1). 
(2) EXCEPTION
FOR
INTELLIGENCE
ACTIVI-
TIES.—Sanctions under this section shall not apply 
to any activity subject to the reporting requirements 
under title V of the National Security Act of 1947 
(50 U.S.C. 3091 et seq.) or any authorized intel-
ligence activities of the United States. 
(3) EXCEPTION RELATING TO IMPORTATION OF 
GOODS.— 
(A) IN GENERAL.—The authorities and re-
quirements to impose sanctions under sub-
VerDate Sep 11 2014 
18:51 Jun 04, 2020
Jkt 099200
PO 00000
Frm 00013
Fmt 6652
Sfmt 6201
E:\BILLS\H6863.IH
H6863
pamtmann on DSKBC07HB2PROD with BILLS
section (c)(1) shall not include the authority or 
a requirement to impose sanctions on the im-
portation of goods. 
(B) GOOD DEFINED.—In this paragraph, 
the term ‘‘good’’ means any article, natural or 
manmade substance, material, supply or manu-
factured product, including inspection and test 
equipment, and excluding technical data. 
(4) EXCEPTION
TO
COMPLY
WITH
INTER-
NATIONAL OBLIGATIONS AND FOR LAW ENFORCE-
MENT
ACTIVITIES.—Sanctions 
under 
subsection 
(c)(2) and the prohibition under subsection (d) shall 
not apply with respect to an alien if admitting or pa-
roling the alien into the United States is nec-
essary— 
(A) to permit the United States to comply 
with the Agreement regarding the Head-
quarters of the United Nations, signed at Lake 
Success June 26, 1947, and entered into force 
November 21, 1947, between the United Na-
tions and the United States, or other applicable 
international obligations; or 
(B) to carry out or assist law enforcement 
activity in the United States. 
(f) IMPLEMENTATION; PENALTIES.— 
VerDate Sep 11 2014 
18:51 Jun 04, 2020
Jkt 099200
PO 00000
Frm 00014
Fmt 6652
Sfmt 6201
E:\BILLS\H6863.IH
H6863
pamtmann on DSKBC07HB2PROD with BILLS
(1) IMPLEMENTATION.—The President may ex-
ercise all authorities provided under sections 203 
and 205 of the International Emergency Economic 
Powers Act (50 U.S.C. 1702 and 1704) to carry out 
this section. 
(2) PENALTIES.—A person that violates, at-
tempts to violate, conspires to violate, or causes a 
violation of this section or any regulation, license, or 
order issued to carry out this section shall be subject 
to the penalties set forth in subsections (b) and (c) 
of section 206 of the International Emergency Eco-
nomic Powers Act (50 U.S.C. 1705) to the same ex-
tent as a person that commits an unlawful act de-
scribed in subsection (a) of that section. 
(g) SUSPENSION; REINSTATEMENT.— 
(1) IN
GENERAL.—The authority to impose 
sanctions or prohibitions under this section, and any 
sanctions or prohibitions so imposed, shall be sus-
pended on the date on which the President submits 
to Congress a certification described in subsection 
(a)(1). 
(2) EFFECT OF SUBSEQUENT FAILURE TO CER-
TIFY.—If, after a suspension of sanctions and prohi-
bitions under paragraph (1), the President is unable 
to submit a certification described in paragraph (1) 
VerDate Sep 11 2014 
18:51 Jun 04, 2020
Jkt 099200
PO 00000
Frm 00015
Fmt 6652
Sfmt 6201
E:\BILLS\H6863.IH
H6863
pamtmann on DSKBC07HB2PROD with BILLS
of subsection (a) at a time required by that sub-
section, the authority to impose sanctions and prohi-
bitions under this section, and any sanctions or pro-
hibitions previously imposed under this section, shall 
be reinstated. 
(h) DEFINITIONS.—In this section: 
(1) ADMISSION; ADMITTED; ALIEN.—The terms 
‘‘admission’’, ‘‘admitted’’, and ‘‘alien’’ have the 
meanings given those terms in section 101 of the 
Immigration and Nationality Act (8 U.S.C. 1101). 
(2) 
UNITED
STATES
PERSON.—The 
term 
‘‘United States person’’ means— 
(A) a United States citizen or an alien law-
fully admitted for permanent residence to the 
United States; or 
(B) an entity organized under the laws of 
the United States or any jurisdiction within the 
United States, including a foreign branch of 
such an entity. 
VerDate Sep 11 2014 
18:51 Jun 04, 2020
Jkt 099200
PO 00000
Frm 00016
Fmt 6652
Sfmt 6201
E:\BILLS\H6863.IH
H6863
pamtmann on DSKBC07HB2PROD with BILLS
TITLE 
II—ENSURING 
A 
SAFE 
AND 
SECURE 
SUPPLY 
OF 
PHARMACEUTICALS FOR THE 
UNITED STATES 
SEC. 201. FOOD AND DRUG ADMINISTRATION REPORTING 
REQUIREMENTS. 
(a) IN GENERAL.—Not later than 180 days after the 
date of the enactment of this Act, and annually thereafter, 
the Commissioner of Food and Drugs shall submit to the 
appropriate congressional committees— 
(1) a list of all brand name and generic drugs 
and corresponding active pharmaceutical ingredients 
that the Commissioner determines are— 
(A) critical to the health and safety of 
United States consumers; and 
(B) are exclusively produced, or incor-
porate active pharmaceutical ingredients pro-
duced, in the People’s Republic of China; 
(2)(A) a certification that the pharmaceutical 
industry in the People’s Republic of China is being 
regulated for safety, either by authorities of the Gov-
ernment of the People’s Republic of China or by the 
Food and Drug Administration, to substantially the 
same degree as the United States pharmaceutical in-
dustry; or 
VerDate Sep 11 2014 
18:51 Jun 04, 2020
Jkt 099200
PO 00000
Frm 00017
Fmt 6652
Sfmt 6201
E:\BILLS\H6863.IH
H6863
pamtmann on DSKBC07HB2PROD with BILLS
(B) if the Commissioner is unable to make a 
certification described in subparagraph (A), a plan 
to protect the people of the United States from un-
safe or contaminated drugs manufactured in the 
People’s Republic of China; and 
(3) a report on imports from the People’s Re-
public of China of all personal protective equipment 
that is intended for use as a medical device, includ-
ing— 
(A) information on the percentage of de-
mand in the United States for such equipment 
that is met by such imports; and 
(B) an analysis of the percentage of such 
imports that meet the standards of the Com-
missioner for use in the United States. 
(b) APPROPRIATE
CONGRESSIONAL
COMMITTEES 
DEFINED.—In this section, the term ‘‘appropriate con-
gressional committees’’ means— 
(1) the Committee on Finance and the Com-
mittee on Health, Education, Labor, and Pensions 
of the Senate; and 
(2) the Committee on Ways and Means and the 
Committee on Energy and Commerce of the House 
of Representatives. 
VerDate Sep 11 2014 
18:51 Jun 04, 2020
Jkt 099200
PO 00000
Frm 00018
Fmt 6652
Sfmt 6201
E:\BILLS\H6863.IH
H6863
pamtmann on DSKBC07HB2PROD with BILLS
TITLE III—ENCOURAGING THE 
RETURN AND DEVELOPMENT 
OF UNITED STATES INDUS-
TRY 
SEC. 301. INCREASE IN ALTERNATIVE SIMPLIFIED RE-
SEARCH CREDIT. 
(a) IN GENERAL.—Subparagraph (A) of section 
41(c)(4) of the Internal Revenue Code of 1986 is amended 
by striking ‘‘14 percent’’ and inserting ‘‘20 percent’’. 
(b) CONFORMING AMENDMENT.—Clause (ii) of sec-
tion 41(c)(4)(B) of the Internal Revenue Code of 1986 
is amended by striking ‘‘6 percent’’ and inserting ‘‘10 per-
cent’’. 
(c) EFFECTIVE DATE.—The amendments made by 
this section shall apply to taxable years beginning after 
December 31, 2019. 
SEC. 302. SPECIAL RULES FOR CERTAIN UNITED STATES 
MANUFACTURERS. 
(a) INCREASE
IN
RESEARCH
CREDIT.—Section 
41(c)(4) of the Internal Revenue Code of 1986 is amended 
by adding at the end the following new subparagraph: 
‘‘(C) SPECIAL RULES FOR QUALIFIED MAN-
UFACTURERS.— 
VerDate Sep 11 2014 
18:51 Jun 04, 2020
Jkt 099200
PO 00000
Frm 00019
Fmt 6652
Sfmt 6201
E:\BILLS\H6863.IH
H6863
pamtmann on DSKBC07HB2PROD with BILLS
‘‘(i) IN GENERAL.—In the case of a 
taxpayer who meets the requirements of 
clause (ii) for the taxable year— 
‘‘(I) subparagraph (A) shall be 
applied by substituting ‘30 percent’ 
for ‘20 percent’, and 
‘‘(II) subparagraph (B)(ii) shall 
be applied by substituting ‘14 percent’ 
for ‘10 percent’. 
‘‘(ii) REQUIREMENTS.— 
‘‘(I) IN
GENERAL.—A taxpayer 
meets the requirements of this clause 
if not less than 50 percent of the 
gross receipts for applicable products 
sold by the taxpayer during the tax-
able year are produced or manufac-
tured in whole or in significant part 
within the United States. 
‘‘(II) APPLICABLE PRODUCTS.— 
For purposes of this clause, the term 
‘applicable product’ means any prod-
uct with respect to which a credit was 
allowed under this section to the tax-
payer in a preceding taxable year.’’. 
VerDate Sep 11 2014 
18:51 Jun 04, 2020
Jkt 099200
PO 00000
Frm 00020
Fmt 6652
Sfmt 6201
E:\BILLS\H6863.IH
H6863
pamtmann on DSKBC07HB2PROD with BILLS
(b) EFFECTIVE DATE.—The amendments made by 
this section shall apply to taxable years beginning after 
December 31, 2019. 
SEC. 303. DOMESTIC PURCHASING REQUIREMENT FOR 
PERSONAL PROTECTIVE EQUIPMENT ACQUI-
SITIONS FOR THE STRATEGIC NATIONAL 
STOCKPILE. 
(a) REQUIREMENT.—Except as provided in sub-
sections (c) and (d), funds appropriated or otherwise avail-
able to the Secretary of Health and Human Services for 
the Strategic National Stockpile may not be used for the 
procurement of an item described in subsection (b) if the 
item is not grown, reprocessed, reused, or produced in the 
United States. 
(b) COVERED ITEMS.—An item described in this sub-
section is an article or item of— 
(1) personal protective equipment or clothing 
and the materials and components thereof, other 
than sensors, electronics, or other items added to, 
and not normally associated with, clothing (and the 
materials and components thereof); 
(2) surgical masks, respirator masks, face 
shields, surgical and privacy gowns, head and foot 
coverings, testing swabs, bedding, or other critical 
medical supplies; 
VerDate Sep 11 2014 
18:51 Jun 04, 2020
Jkt 099200
PO 00000
Frm 00021
Fmt 6652
Sfmt 6201
E:\BILLS\H6863.IH
H6863
pamtmann on DSKBC07HB2PROD with BILLS
(3) cotton and other natural fiber products, 
woven silk or woven silk blends, spun silk yarn for 
cartridge cloth, synthetic fabric or coated synthetic 
fabric (including all textile fibers and yarns that are 
for use in such fabrics), canvas products, or wool 
(whether in the form of fiber or yarn or contained 
in fabrics, materials, or manufactured articles); or 
(4) any item of individual equipment manufac-
tured from or containing such fibers, yarns, fabrics, 
or materials. 
(c) AVAILABILITY EXCEPTION.—Subsection (a) shall 
not apply to the extent that the Secretary of Health and 
Human Services determines that a sufficient quantity of 
a satisfactory quality of any such article or item described 
in subsection (b) that is grown, reprocessed, reused, or 
produced in the United States cannot be procured as, and 
when, needed at United States market prices. This section 
shall not apply to covered items that are, or include, mate-
rials determined to be nonavailable in accordance with 
Federal Acquisition Regulation 25.104 Nonavailable Arti-
cles. 
(d) EXCEPTION
FOR
SMALL
PURCHASES.—Sub-
section (a) shall not apply to purchases for amounts that 
do not exceed $150,000. A proposed purchase or contract 
for an amount in excess of $150,000 may not be divided 
VerDate Sep 11 2014 
18:51 Jun 04, 2020
Jkt 099200
PO 00000
Frm 00022
Fmt 6652
Sfmt 6201
E:\BILLS\H6863.IH
H6863
pamtmann on DSKBC07HB2PROD with BILLS
into several purchases or contracts for lesser amounts in 
order to qualify for the exception under this subsection. 
(e) GEOGRAPHIC COVERAGE.—In this section, the 
term ‘‘United States’’ includes the possessions of the 
United States. 
(f) NOTIFICATION REQUIRED WITHIN 7 DAYS AFTER 
CONTRACT AWARD IF CERTAIN EXCEPTIONS APPLIED.— 
In the case of any contract for the procurement of an item 
described in subsection (b), if the Secretary of Health and 
Human Services applies the exception described in sub-
section (c) with respect to that contract, the Secretary 
shall, not later than 7 days after the awarding of the con-
tract, post a notification that the exception has been ap-
plied on the internet website maintained by the General 
Services Administration known as FedBizOps.gov (or any 
successor site). 
(g) TRAINING DURING FISCAL YEAR 2021.— 
(1) IN GENERAL.—The Secretary of Health and 
Human Services shall ensure that each member of 
the acquisition workforce in the Department of 
Health and Human Services who participates per-
sonally and substantially in acquisitions on a regular 
basis receives training during fiscal year 2021 on 
the requirements of this section and the regulations 
implementing this section. 
VerDate Sep 11 2014 
18:51 Jun 04, 2020
Jkt 099200
PO 00000
Frm 00023
Fmt 6652
Sfmt 6201
E:\BILLS\H6863.IH
H6863
pamtmann on DSKBC07HB2PROD with BILLS
(2) INCLUSION
OF
INFORMATION
IN
NEW 
TRAINING PROGRAMS.—The Secretary of Health and 
Human Services shall ensure that any training pro-
gram for the acquisition workforce developed or im-
plemented after fiscal year 2021, includes com-
prehensive information on the requirements de-
scribed in paragraph (1). 
(h) APPLICATION TO OTHER AGENCIES.—If respon-
sibility for maintaining the Strategic National Stockpile 
is transferred from the Department of Health and Human 
Services to any other Federal department or agency, the 
provisions of this section shall apply to the head of such 
department or agency. 
(i) EFFECTIVE DATE.—This section shall apply with 
respect to contracts entered into by the Department of 
Health and Human Services beginning 60 days after the 
date of enactment of this Act. 
TITLE IV—MATTERS RELATING 
TO TAIWAN 
SEC. 401. PARTICIPATION OF TAIWAN IN THE WORLD 
HEALTH ORGANIZATION. 
(a) FINDINGS.—Congress makes the following find-
ings: 
(1) The World Health Organization (WHO) is 
a specialized agency of the United Nations, charged 
VerDate Sep 11 2014 
18:51 Jun 04, 2020
Jkt 099200
PO 00000
Frm 00024
Fmt 6652
Sfmt 6201
E:\BILLS\H6863.IH
H6863
pamtmann on DSKBC07HB2PROD with BILLS
with coordinating health efforts within the United 
Nations system. The World Health Assembly 
(WHA) is the decision-making body of the WHO, 
which convenes annually in May to set the policies 
and priorities of the organization. Statehood is not 
a requirement for attendance at the WHA, and nu-
merous observers, including nonmembers and non-
governmental organizations, attended the most re-
cent WHA in May 2018. 
(2) Taiwan began seeking to participate in the 
WHO as an observer in 1997. In 2009, with strong 
support from successive United States Administra-
tions, Congress, and like-minded WHO Member 
States, and during a period of improved Cross-Strait 
relations, Taiwan received an invitation to attend 
the WHA as an observer under the name ‘‘Chinese 
Taipei’’. Taiwan received the same invitation each 
year until 2016, when following the election of Presi-
dent Tsai-Ing Wen of the Democratic Progressive 
Party, Taiwan’s engagement in the international 
community began facing increased resistance from 
the People’s Republic of China (PRC). Taiwan’s in-
vitation to the 2016 WHA was received late and in-
cluded new language conditioning Taiwan’s partici-
pation on the PRC’s ‘‘one China principle’’. In 2017 
VerDate Sep 11 2014 
18:51 Jun 04, 2020
Jkt 099200
PO 00000
Frm 00025
Fmt 6652
Sfmt 6201
E:\BILLS\H6863.IH
H6863
pamtmann on DSKBC07HB2PROD with BILLS
and 2018, Taiwan did not receive an invitation to 
the WHA. 
(3) Taiwan remains a model contributor to 
world health, having provided financial and technical 
assistance to respond to numerous global health 
challenges. 
Taiwan 
has 
invested 
over 
$6,000,000,000 in international medical and human-
itarian aid efforts impacting over 80 countries since 
1996. In 2014, Taiwan responded to the Ebola crisis 
by donating $1,000,000 and providing 100,000 sets 
of personal protective equipment. Through the Glob-
al Cooperation and Training Framework, the United 
States and Taiwan have jointly conducted training 
programs for experts to combat MERS, Dengue 
Fever, and Zika. These diseases know no borders, 
and Taiwan’s needless exclusion from global health 
cooperation increases the dangers presented by glob-
al pandemics. 
(4) Taiwan’s international engagement has 
faced increased resistance from the PRC. Taiwan 
was not invited to the 2016 Assembly of the Inter-
national Civil Aviation Organization (ICAO), despite 
participating as a guest at the organization’s prior 
summit in 2013. Taiwan’s requests to participate in 
the General Assembly of the International Criminal 
VerDate Sep 11 2014 
18:51 Jun 04, 2020
Jkt 099200
PO 00000
Frm 00026
Fmt 6652
Sfmt 6201
E:\BILLS\H6863.IH
H6863
pamtmann on DSKBC07HB2PROD with BILLS
Police Organization (INTERPOL) have also been 
rejected. In May 2017, PRC delegates disrupted a 
meeting of the Kimberley Process on conflict dia-
monds held in Perth, Australia, until delegates from 
Taiwan were asked to leave. Since 2016, the Demo-
cratic Republic of Sa˜o Tome´ and Prı´ncipe, the Re-
public of Panama, the Dominican Republic, Burkina 
Faso, the Republic of El Salvador, the Solomon Is-
lands, and Kiribati have terminated longstanding 
diplomatic relationships with Taiwan and granted 
diplomatic recognition to the PRC. 
(5) Congress has established a policy of support 
for Taiwan’s participation in international bodies 
that address shared transnational challenges, par-
ticularly in the WHO. Congress passed H.R. 1794 
in the 106th Congress, H.R. 428 in the 107th Con-
gress, and S. 2092 in the 108th Congress to direct 
the Secretary of State to establish a strategy for, 
and to report annually to Congress on, efforts to ob-
tain observer status for Taiwan at the WHA. Con-
gress also passed H.R. 1151 in the 113th Congress, 
directing the Secretary to report on a strategy to 
gain observer status for Taiwan at the ICAO Assem-
bly, and H.R. 1853 in the 114th Congress, directing 
the Secretary to report on a strategy to gain ob-
VerDate Sep 11 2014 
18:51 Jun 04, 2020
Jkt 099200
PO 00000
Frm 00027
Fmt 6652
Sfmt 6201
E:\BILLS\H6863.IH
H6863
pamtmann on DSKBC07HB2PROD with BILLS
server status for Taiwan at the INTERPOL Assem-
bly. However, since 2017 Taiwan has not received 
an invitation to attend any of these events as an ob-
server. 
(b) AUGMENTATION OF REPORT CONCERNING THE 
PARTICIPATION OF TAIWAN IN THE WORLD HEALTH OR-
GANIZATION.— 
(1) IN GENERAL.—Subsection (c) of section 1 
of Public Law 108–235 (118 Stat. 656) is amended 
by adding at the end the following new paragraph: 
‘‘(3) An account of the changes and improve-
ments the Secretary of State has made to the 
United States plan to endorse and obtain observer 
status for Taiwan at the World Health Assembly, 
following any annual meetings of the World Health 
Assembly at which Taiwan did not obtain observer 
status.’’. 
(2) EFFECTIVE DATE.—The amendment made 
by paragraph (1) shall take effect and apply begin-
ning with the first report required under subsection 
(c) of section 1 of Public Law 108–235 that is sub-
mitted after the date of the enactment of this Act. 
VerDate Sep 11 2014 
18:51 Jun 04, 2020
Jkt 099200
PO 00000
Frm 00028
Fmt 6652
Sfmt 6201
E:\BILLS\H6863.IH
H6863
pamtmann on DSKBC07HB2PROD with BILLS
SEC. 402. BRIEFING ON UNITED STATES STRATEGY RE-
GARDING TAIWAN’S INTERNATIONAL REC-
OGNITION. 
(a) IN GENERAL.—Not later than 90 days after the 
date of the enactment of this Act, and every 180 days 
thereafter for 3 years, the Secretary of State shall provide 
to the appropriate congressional committees a briefing on 
actions taken by the United States to reaffirm and 
strengthen Taiwan’s official and unofficial diplomatic rela-
tionships. 
(b) ELEMENTS.—The briefing required by subsection 
(a) shall include the following elements: 
(1) A description of the actions taken by the 
United States commencing May 20, 2016, to consult 
with governments around the world, including the 
governments that maintain official diplomatic rela-
tions with Taiwan, with the purpose of inducing 
those governments to maintain official diplomatic re-
lations with Taiwan or otherwise strengthen unoffi-
cial relations with Taiwan. 
(2) An enumeration of specific countries of con-
cern, if any, and a description of the actions taken, 
or actions anticipated, by those governments, com-
mencing May 20, 2016, to alter the formal diplo-
matic ties with Taiwan or to otherwise downgrade 
official or unofficial relations. 
VerDate Sep 11 2014 
18:51 Jun 04, 2020
Jkt 099200
PO 00000
Frm 00029
Fmt 6652
Sfmt 6201
E:\BILLS\H6863.IH
H6863
pamtmann on DSKBC07HB2PROD with BILLS
(3) A plan of action to engage with the govern-
ments of the countries identified in paragraphs (1) 
and (2) and increase cooperation with respect to 
Taiwan. 
(c) APPROPRIATE CONGRESSIONAL COMMITTEES.— 
In this section, the term ‘‘appropriate congressional com-
mittees’’ means— 
(1) the Committee on Foreign Relations of the 
Senate; and 
(2) the Committee on Foreign Affairs of the 
House of Representatives. 
SEC. 403. SENSE OF CONGRESS ON THE IMPLEMENTATION 
OF THE ASIA REASSURANCE INITIATIVE ACT. 
It is the sense of Congress that the full and timely 
implementation of section 209 of the Asia Reassurance 
Initiative Act of 2018 (Public Law 115–409; 132 Stat. 
5387), which reiterates longstanding bipartisan United 
States policy, is critical to demonstrate United States sup-
port for Taiwan. 
Æ 
VerDate Sep 11 2014 
18:51 Jun 04, 2020
Jkt 099200
PO 00000
Frm 00030
Fmt 6652
Sfmt 6301
E:\BILLS\H6863.IH
H6863
pamtmann on DSKBC07HB2PROD with BILLS